Biopharma Business

Tag "drug safety"

EMA examines key Actelion med Uptravi following 5 patient deaths in France

Johnson & Johnson is counting on new buy Actelion’s pulmonary arterial hypertension (PAH) meds to provide a top-line boost once its $30 billion transaction closes. But one of them may

Read Full Article

Upcoming Events


The Magazine

New Subscriber

Subscribe Here